Clinical decision making and health care policy: what is the link?

Health Policy ◽  
1989 ◽  
Vol 11 (1) ◽  
pp. 19-25 ◽  
Author(s):  
Gavin Mooney ◽  
Anne Loft
2012 ◽  
Vol 33 (1) ◽  
pp. E16 ◽  
Author(s):  
Jonathan R. Slotkin ◽  
Alfred S. Casale ◽  
Glenn D. Steele ◽  
Steven A. Toms

Comparative effectiveness research (CER) represents an evolution in clinical decision-making research that allows for the study of heterogeneous groups of patients with complex diseases processes. It has foundations in decision science, reliability science, and health care policy research. Health care finance will increasingly rely on CER for guidance in the coming years. There is increasing awareness of the importance of decreasing unwarranted variation in health care delivery. In the past 7 years, Geisinger Health System has performed broad reengineering of its acute episodic and chronic care delivery models utilizing macrosystem-level application of CER principles. These provider-driven process initiatives have resulted in significant improvement across all segments of care delivery, improved patient outcomes, and notable cost containment. These programs have led to the creation of novel pricing models, and when “hardwired” throughout a care delivery system, they can lead to correct medical decision making by 100% of providers in all patient encounters. Neurosurgery as a specialty faces unique challenges and opportunities with respect to broad adoption and application of CER techniques.


2008 ◽  
Vol 36 (1) ◽  
pp. 95-118 ◽  
Author(s):  
Giles R. Scofield

As everybody knows, advances in medicine and medical technology have brought enormous benefits to, and created vexing choices for, us all – choices that can, and occasionally do, test the very limits of thinking itself. As everyone also knows, we live in the age of consultants, i.e., of professional experts who are ready, willing, and able to give us advice on any and every conceivable question. One such consultant is the medical ethics consultant, or the medical ethicist who consults.Medical ethics consultants involve themselves in just about every aspect of health care decision making. They help legislators and judges determine law, hospitals formulate policies, medical schools develop curricula, etc. In addition to educating physicians, nurses, and lawyers, amongst others, including medical, nursing, and law students, they participate in clinical decision making at the bedside.


1999 ◽  
Vol 15 (3) ◽  
pp. 585-592 ◽  
Author(s):  
Alicia Granados

This paper examines the rationality of the concepts underlying evidence—based medicineand health technology assessment (HTA), which are part of a new current aimed at promoting the use of the results of scientific studies for decision making in health care. It describes the different approaches and purposes of this worldwide movement, in relation to clinical decision making, through a summarized set of specific HTA case studies from Catalonia, Spain. The examples illustrate how the systematic process of HTA can help in several types of uncertainties related to clinical decision making.


Author(s):  
Jennifer Wolak

This chapter reports a set of experiments that consider people’s appraisals of specific policy compromises in Congress, focusing on whether people like compromises less once they understand what types of policy concessions they entail. Drawing on recent congressional compromises on domestic violence legislation, education reform, and health-care policy, the experiments test whether people evaluate Congress and its policy outcomes differently when bills are represented as compromises where both sides made concessions in order to achieve policy gains. The results show that people are disappointed when they learn that a bill failed to pass due to members of Congress refusing to compromise. Members of Congress do not seem to be penalized for their support of compromise legislation. Policy compromises serve to boost the perceived legitimacy of the decision-making process, particularly among those who are ideologically opposed to the outcome.


Science ◽  
2015 ◽  
Vol 350 (6266) ◽  
pp. 1397-1397
Author(s):  
R. Rosenquist Brandell ◽  
O. Kallioniemi ◽  
A. Wedell

2012 ◽  
Vol 8 (3S) ◽  
pp. 22s-27s ◽  
Author(s):  
Anthony Wang ◽  
Ronald J. Halbert ◽  
Tiffany Baerwaldt ◽  
Robert J. Nordyke

To improve formulary design processes and support payers in providing more effective health care, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.


Sign in / Sign up

Export Citation Format

Share Document